Vaccination against Herpes zoster in patients with immune-mediated inflammatory rheumatic diseases: new data
Patients with immune-mediated inflammatory rheumatic diseases (IIRD) are more likely to develop herpes zoster (HZ) than individuals in the general population. Live attenuated vaccines and inactivated recombinant vaccines with adjuvant are available to prevent the disease and its complications. Live...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
IMA-PRESS LLC
2024-08-01
|
| Series: | Современная ревматология |
| Subjects: | |
| Online Access: | https://mrj.ima-press.net/mrj/article/view/1629 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849691657694347264 |
|---|---|
| author | N. V. Muravyova B. S. Belov |
| author_facet | N. V. Muravyova B. S. Belov |
| author_sort | N. V. Muravyova |
| collection | DOAJ |
| description | Patients with immune-mediated inflammatory rheumatic diseases (IIRD) are more likely to develop herpes zoster (HZ) than individuals in the general population. Live attenuated vaccines and inactivated recombinant vaccines with adjuvant are available to prevent the disease and its complications. Live attenuated vaccine can be used in patients with IIRD if certain conditions are met, although these cannot always be fulfilled. The advantage of the inactivated recombinant adjuvant vaccine is that it can be used against a background of anti-rheumatic therapy. The review analyzes foreign studies on the safety, immunogenicity and efficacy of recombinant adjuvant vaccine against HZ in patients with IIRD. |
| format | Article |
| id | doaj-art-10edb354788743cdbfd6f9cbd64211e8 |
| institution | DOAJ |
| issn | 1996-7012 2310-158X |
| language | Russian |
| publishDate | 2024-08-01 |
| publisher | IMA-PRESS LLC |
| record_format | Article |
| series | Современная ревматология |
| spelling | doaj-art-10edb354788743cdbfd6f9cbd64211e82025-08-20T03:20:58ZrusIMA-PRESS LLCСовременная ревматология1996-70122310-158X2024-08-0118411512010.14412/1996-7012-2024-4-115-1202711Vaccination against Herpes zoster in patients with immune-mediated inflammatory rheumatic diseases: new dataN. V. Muravyova0B. S. Belov1V.A. Nasonova Research Institute of RheumatologyV.A. Nasonova Research Institute of RheumatologyPatients with immune-mediated inflammatory rheumatic diseases (IIRD) are more likely to develop herpes zoster (HZ) than individuals in the general population. Live attenuated vaccines and inactivated recombinant vaccines with adjuvant are available to prevent the disease and its complications. Live attenuated vaccine can be used in patients with IIRD if certain conditions are met, although these cannot always be fulfilled. The advantage of the inactivated recombinant adjuvant vaccine is that it can be used against a background of anti-rheumatic therapy. The review analyzes foreign studies on the safety, immunogenicity and efficacy of recombinant adjuvant vaccine against HZ in patients with IIRD.https://mrj.ima-press.net/mrj/article/view/1629immune-inflammatory rheumatic diseasesrheumatoid arthritissystemic lupus erythematosusglucocorticoidsjanus kinase inhibitorsbiologic disease-modifying antirheumatic drugsherpes zostervaccinationrecombinant adjuvant vaccine |
| spellingShingle | N. V. Muravyova B. S. Belov Vaccination against Herpes zoster in patients with immune-mediated inflammatory rheumatic diseases: new data Современная ревматология immune-inflammatory rheumatic diseases rheumatoid arthritis systemic lupus erythematosus glucocorticoids janus kinase inhibitors biologic disease-modifying antirheumatic drugs herpes zoster vaccination recombinant adjuvant vaccine |
| title | Vaccination against Herpes zoster in patients with immune-mediated inflammatory rheumatic diseases: new data |
| title_full | Vaccination against Herpes zoster in patients with immune-mediated inflammatory rheumatic diseases: new data |
| title_fullStr | Vaccination against Herpes zoster in patients with immune-mediated inflammatory rheumatic diseases: new data |
| title_full_unstemmed | Vaccination against Herpes zoster in patients with immune-mediated inflammatory rheumatic diseases: new data |
| title_short | Vaccination against Herpes zoster in patients with immune-mediated inflammatory rheumatic diseases: new data |
| title_sort | vaccination against herpes zoster in patients with immune mediated inflammatory rheumatic diseases new data |
| topic | immune-inflammatory rheumatic diseases rheumatoid arthritis systemic lupus erythematosus glucocorticoids janus kinase inhibitors biologic disease-modifying antirheumatic drugs herpes zoster vaccination recombinant adjuvant vaccine |
| url | https://mrj.ima-press.net/mrj/article/view/1629 |
| work_keys_str_mv | AT nvmuravyova vaccinationagainstherpeszosterinpatientswithimmunemediatedinflammatoryrheumaticdiseasesnewdata AT bsbelov vaccinationagainstherpeszosterinpatientswithimmunemediatedinflammatoryrheumaticdiseasesnewdata |